Ewing sarcoma

Indexed in Crossref

5 abstracts matching ewing sarcoma from the meeting's journal supplement, fetched live from Crossref 2026-11-12 07:54 UTC. This is a keyword search, not the complete abstract book.

• E23507
  Impact of primary tumor location on treatment and outcomes in Ewing sarcoma.

  Saif Salih, Dylan Riley, Michael Fice, Alan T. Blank
• E23501
  Genotype–anatomic correlates and survival outcomes in a molecularly validated 90-patient cohort of skeletal and extraskeletal Ewing sarcomas and mimics.

  Abdulaziz AlJassim, Rola Ali, Muath A.M.A.H Alnassar, Shakir Bahzad et al.
• 11510
  Phase 1/2 study of YL201, an anti-B7H3 antibody–drug conjugate (ADC), in patients with relapsed or refractory (R/R) Ewing sarcoma and chondrosarcoma.

  Lu Xie, Jie Zang, Yuwei Zhao, Yiyang Yu et al.
• TPS10057
  A phase 1b study of xaluritamig (a STEAP1 x CD3 T-cell engager) in pediatric, adolescent, and adult patients with relapsed/refractory (R/R) Ewing sarcoma.

  Emily K. Slotkin, Leo Mascarenhas, Kelly Bailey, Jeremy Howard Lewin et al.
• 11518
  Safety and pharmacokinetics (PK) of lurbinectedin (lurbi) in pediatric patients (pts) with relapsed/refractory (R/R) solid tumors and preliminary antitumor activity in pediatric and young adult pts with R/R Ewing sarcoma (EwS): Results from a phase 1 study.

  Julia Lynne Glade Bender, Joseph Gerald Pressey, Lars M. Wagner, AeRang Kim et al.